Orexo R&D Day on March 24
UPPSALA, Sweden, March 6, 2026 /PRNewswire/ — Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY) today invites investors, analysts and media…
Read More
The Times Of Bengal
For You Forever Yours
Orexo R&D Day on March 24
UPPSALA, Sweden, March 6, 2026 /PRNewswire/ — Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY) today invites investors, analysts and media…
Read More
Epilepsy Foundation of America Partners with SeizeSense to Expand Seizure Safety Awareness Nationwide
A Public Service Announcement Created by SeizeSense to Run in AMC Theatres Across the United States BOWIE, Md., March 6,…
Read More
Perspire Sauna Studio Launches Halotherapy Nationwide
“The addition of Halotherapy across our entire system deepens the value of each session…” – Lee Braun, Founder & CEO…
Read More
The First AI Agent to Transform Patient Affordability
LAS VEGAS, March 6, 2026 /PRNewswire/ — Atlas Health, the leader in patient affordability automation, has launched the first AI…
Read More
Orexo changes the organizational structure and management team to increase focus on development of new products
UPPSALA, Sweden, March 6, 2026 /PRNewswire/ — Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces changes to its organizational structure and…
Read More
Chemiluminescence Immunoassay Market worth $16.39 billion by 2031
DELRAY BEACH, Fla., March 6, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Chemiluminescence Immunoassay Market is projected to grow from…
Read More
Servier et Day One Biopharmaceuticals annoncent un accord d’acquisition qui renforce le portefeuille de Servier dans les cancers rares
Cette acquisition positionne Servier comme un leader dans le gliome de bas grade pédiatrique et renforce son pipeline avec des…
Read More
Orexo changes the organizational structure and management team to increase focus on development of new products
UPPSALA, Sweden, March 6, 2026 /PRNewswire/ — Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces changes to its organizational structure and…
Read More
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric…
Read More
